Sign in to continue:

Saturday, March 7th, 2026

Greentech Technology Announces Change of Board Meeting Date and Continued Trading Suspension on HKEX





Greentech Technology International Limited – Key Investor Update

Greentech Technology International Limited: Key Updates for Investors

Summary of the Latest Announcement

  • Change of Date for Board Meeting: The board meeting initially scheduled for 6 March 2026 has been postponed to 13 March 2026.
  • Reason for Postponement: The company requires additional time to finalize both the audited annual results for the year ended 31 December 2024 and the unaudited interim results for the six months ended 30 June 2025.
  • Continued Suspension of Trading: Trading in Greentech Technology International Limited’s shares has been suspended since 2 September 2024, due to a delay in publishing the unaudited interim results for the six months ended 30 June 2024. The suspension will remain until the company meets the Resumption Guidance set by the Hong Kong Stock Exchange.

Details Investors Should Note

1. Ongoing Trading Suspension: The company’s shares remain suspended from trading, which is a significant issue for shareholders and potential investors. The suspension was triggered by the delay in the publication of financial results, which raises concerns about transparency and financial reporting processes within the company.

2. Delay in Financial Results: The audited annual results for FY2024 and the unaudited interim results for the first half of 2025 are both delayed. Such delays often point to underlying financial, administrative, or operational challenges. The inability to publish timely results is considered a critical red flag in public companies, as it can impact investor confidence and the market’s perception of the company’s governance and financial health.

3. Resumption Guidance Must Be Met: The Hong Kong Stock Exchange has imposed specific Resumption Guidance that Greentech Technology International Limited must fulfill before trading can resume. This guidance likely includes the publication of overdue financial results, demonstrating the company’s ability to comply with listing rules, and possibly other remedial actions. Failure to meet this guidance could result in prolonged suspension or further regulatory actions.

4. Board Composition: The announcement also lists the current board members, including five executive directors and three independent non-executive directors. The presence of experienced directors may provide some reassurance, but the ongoing issues with financial reporting remain a serious concern.

Potential Price Sensitivity

  • Trading suspension and delayed results are highly price sensitive events. Investors should monitor the company’s ability to resolve these issues quickly. Any further delays or negative disclosures could lead to further loss in shareholder value once trading resumes.
  • The company’s ability to meet the Resumption Guidance and restore trading will be a critical event for share price recovery. The outcome of the rescheduled board meeting on 13 March 2026 will be closely watched by the market.
  • Shareholders should be alert for further announcements and updates regarding the financial results and resumption of trading.

Conclusion

Greentech Technology International Limited is currently facing significant challenges regarding its financial reporting and regulatory compliance. The continued suspension of trading, coupled with delays in publishing key financial results, presents both risk and uncertainty for existing shareholders and potential investors. The market will be paying close attention to the company’s next steps, particularly the outcome of the rescheduled board meeting and the company’s ability to fulfill the Stock Exchange’s requirements to resume trading.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors are advised to conduct their own research or consult with a qualified financial advisor before making investment decisions. The author and publisher assume no responsibility for any actions taken based on the information provided herein.




View GREENTECH INTL Historical chart here



Sino Biopharm’s Rovadicitinib Tablet Approved in China as First-Line Treatment for Myelofibrosis, Shows Superior Efficacy and Safety 12

Sino Biopharmaceutical’s Rovadicitinib Tablet Approved for Marketing in China: Key Details for Investors Sino Biopharmaceutical’s Rovadicitinib Tablet Receives Landmark Approval in China Key Highlights and Investor-Relevant Insights First-in-Class Approval: Sino Biopharmaceutical Limited (HKEX: 1177)...

Public Disclosure of Securities Dealings by Morgan Stanley in ENN Energy Holdings Limited Privatisation Scheme (March 2026)

Significant Derivatives Dealings in ENN Energy Holdings Amidst Privatisation Scheme Significant Derivatives Dealings in ENN Energy Holdings Amidst Privatisation Scheme Key Highlights from the Public Disclosure Morgan Stanley & Co., International plc, a Class...

Public Disclosure of Securities Dealings by Morgan Stanley Capital Services LLC in Bright Smart Securities & Commodities Group Limited (March 2026)

Significant Derivatives Dealings in Bright Smart Securities & Commodities Group Limited Disclosed by Morgan Stanley Capital Services LLC Key Disclosure: Major Derivatives Dealings in Bright Smart Securities & Commodities Group Limited On 4 March...

   Ad